Stericycle's high P/S ratio may be due to expectations of a revenue turnaround. However, with weak revenue growth and a higher industry growth forecast, the elevated P/S ratio may not be justified and could fall if revenue sentiment doesn't improve. Current prices may not be reasonable unless conditions significantly improve.
Repeated insider purchases of Stericycle, Inc.'s shares at near current price indicate optimism about the company's future. Despite no recent quarter insider trading, the holdings hint at alignment between insiders and shareholders, although insider ownership is not particularly high.
Stericycle's declining ROCE and capital employed may signify competitive challenges or deterioration of its business advantage, indicating that the company may have moved beyond its growth phase, causing investor concern.
Investors are let down by Stericycle's lack of profit and revenue growth. However, the company making progress amidst negative sentiment could offer an opportunity. Insiders buying shares is a good sign, yet revenue and earnings growth trends still hold more importance.
消毒循環股票討論區
專欄Top upgrades and downgrades on 5/12
•$美國雅保(ALB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $285 (from $215)
• $Alcon(ALC.US)$ : Stephens Upgrades to Overweight from EqualWeight - PT $92 (from $86)
• $Atlantica Sustainable Infrastructure(AY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $33 (from $38)
• $Coupang(CPNG.US)$ : Citigroup Upgrades to Buy from Neutral - PT $15 (from $29)
• $89bio(ETNB.US)$ : Raymond James Upgrades to Strong Buy from Outp...
PreMarket Watch List and Midday
$孩之寶(HAS.US)$
$Universal Health Services(UHS.US)$
$窺得兒醫藥(QDEL.US)$
$消毒循環(SRCL.US)$
$Medpace(MEDP.US)$ $羅傑斯(ROG.US)$
$PJT Partners(PJT.US)$
暫無評論